SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Filing Date
Feb 13, 2009
Document Date
Feb 13, 2009
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC
Filer
BRIDGER MANAGEMENT LLC